US Patent 9067998 Targeting PD-1 variants for treatment of cancer
Patent 9067998 was granted and assigned to Kymab on June, 2015 by the United States Patent and Trademark Office.
Something went wrong.
Try refreshing the page.
Find more entities like US Patent 9067998 Targeting PD-1 variants for treatment of cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
